ARE vs RPRX · P/E 100, rev $662.8M vs P/E 15, rev $1.30B
Alexandria Real Estate Equities Inc (ARE) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported ARE revenue for 2026-06-30 was $662.8M. Net income was -$72.8M. Revenue was down 1.2% from 2026-03-31 to 2026-06-30. ARE currently screens at market cap $13.19B and trailing P/E 100.4.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
ARE currently screens at market cap $13.19B and trailing P/E 100.4. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the ARE and RPRX stock pages for the full models.
Not investment advice.